Motley Fool Australia Chief Investment Officer Scott Phillips joined Peter Overton on Nine’s Late News on Sunday night to discuss the big economic week ahead, including an RBA board meeting, new car sales, jobs data, international trade and more…

The post The week ahead: RBA meeting, new car sales, and jobs data. Scott Phillips on Nine’s Late News appeared first on The Motley Fool Australia.

More reading

• Up 5%, the Webjet (ASX:WEB) share price is back to March 2020 levels. Here’s why
• It’s been a rollercoaster for the CSL (ASX:CSL) share price over the last 6 months
• Xtek (ASX:XTE) share price sinks 23% on capital raising efforts
• Why did the Fortescue (ASX:FMG) share price have such a lousy month in September?
• 2 leading ASX e-commerce shares that could be buys in October 2021

Motley Fool contributor Scott Phillips has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3mf3vTe

The Webjet Ltd (ASX: WEB) share price joins the list of bullish travel and airline shares on Monday, trading at levels not seen since late March last year.

At the time of writing, Webjet shares are up 4.95% to $6.79.

Webjet share price re-rates on Australian travel optimism

The travel industry is gathering momentum amid hopes of reopened borders as soon as next month.

Prime Minister Scott Morrison announced last Friday that international borders are set to reopen in November for states that reach the 80 per cent vaccination prerequisite.

The government is finalising new arrangements for fully vaccinated Australians and permanent residents arriving in NSW. It’s expected arrivals will be able to home quarantine for a week instead of being forced into an expensive two-week hotel quarantine.

Mr Morrison said that “once changes are made in November, the current overseas travel restrictions related to COVID-19 will be removed and Australians will be able to travel subject to another travel advice and limits”.

The positive news helped the Webjet share price withstand the sharp selloff last Friday when the S&P/ASX 200 Index (ASX: XJO) plunged 2%.

White House to lift travel restrictions by November

Similarly, the White House announced on 23 September that it will also be lifting travel restrictions for fully vaccinated travellers from select countries.

The list of 33 countries includes China, India, Brazil and most of Europe. Unfortunately, Australia was not one of them.

Nonetheless, the Webjet share price still rallied 5.22% to $6.25 on the day of the announcement.

International travel stocks jump last Friday

The US Global Jets Exchange Traded Fund (ETF) rallied 5.33% on heavy volume to a 3-month high last Friday night.

By US market close, 15.9 million shares had traded hands compared to the ETF’s 10-day average of 8.8 million.

The Jets ETF tracks an index of companies involved in the air travel industry, including airline operators, airports and terminal services. The bulk of its holdings are in US-listed airlines, with smaller allocations in the likes of Sydney Airport Holdings Pty Ltd (ASX: SYD) and Qantas Airways Limited (ASX: QAN).

The post Up 5%, the Webjet (ASX:WEB) share price is back to March 2020 levels. Here’s why appeared first on The Motley Fool Australia.

More reading

• Here’s why the Webjet (ASX:WEB) share price gained 29% last quarter
• Why the Webjet (ASX:WEB) share price is on the rise today
• 2 ASX shares that could be buys in October 2021
• Why this top broker rates the Webjet (ASX:WEB) share price a buy
• 5 things to watch on the ASX 200 on Wednesday

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Webjet Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3uJudaz

It’s been a bumpy ride for CSL Limited (ASX: CSL) shareholders this past 6 months.

For those who can’t stomach extreme volatility, CSL shares wouldn’t have been an appropriate choice over the last half year.

Nonetheless, CSL shareholders have been rewarded with a 10% return for holding in this time – almost double the S&P/ASX 200 index (ASX: XJO)’s gain of 5.7%.

Let’s take a closer look at the trek CSL shares have been on lately.

How has the CSL share price performed this past 6 months?

All in all, CSL shares have climbed $27 per share since April and now trade at $290, after sailing through choppy waters.

After rallying from $263 to $305 in months from April to June, a broker downgrade out of investment bank giant Citibank appears to have plagued the biotechnology company’s share price at that point.

It fell sharply from the peak in June to a low of $275 by the following month. It popped again in mid-July after it appointed a new non-executive director, and then again in August after the release of its FY21 results.

In its earnings report, the company outperformed on guidance. It grew revenue 10% year on year to $10 billion and net profit by 10% as well to $2.3 billion – well above guidance of 3% to 8% growth.

CSL shares have been on the move since this event, nearly reaching their 52-week high by the end of September.

However, the CSL share price has taken a step backwards since then, in line with a selloff in the broader markets.

For instance, CSL shares have given away 7% this past month, whereas, at last check, the S&P/ASX 200 Health Care index (XHJ) has also slipped over 6% in this time.

Most of this has occurred in the last few weeks, where CSL shares have slipped over 7% since 23 September, in line with the broad index.

In light of this, it’s clear to see that it’s been a bumpy ride for CSL shareholders this past 6 months, with big swings in the value of their holdings.

Zooming out the CSL share price

Taking a longer-term view, the situation appears very much the same. The CSL share price has gained 2.4% this year to date, and 1.9% over the last 12 months.

Looking at its chart, however, over this time, there are big swings in price and a wide 12-month range of $316.68 to $246.

After rallying over the past 2 months, CSL’s share price has cooled off lately and currently trades at its July 2021 levels of $290.

The post It’s been a rollercoaster for the CSL (ASX:CSL) share price over the last 6 months appeared first on The Motley Fool Australia.

More reading

• 2 beaten-up ASX shares now ready to rally: expert
• The CSL (ASX:CSL) share price is down 8% this week. Is it a bargain?
• 5 things to watch on the ASX 200 on Thursday
• Why CSL, Domino’s, Temple & Webster, & Xero shares are tumbling
• The healthcare sector is weighing on the ASX 200 on Tuesday

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3FppHDh

The Xtek Ltd (ASX: XTE) share price is freefalling on Monday following the company’s update on its latest equity raise.

At the time of writing, the defence contractor’s shares are fetching for 28 cents, down 23.29%.

What did Xtek announce?

Investors are heading for the hills after Xtek shares came out of a trading halt today.

According to an announcement this morning, Xtek advised it has successfully completed an underwritten institutional placement. The offer received interest from both new and existing institutional investors, raising $2.7 million.

Xtek will issue around 10.4 million ordinary shares under the placement. The price for each share is set at 26 cents apiece, reflecting a 28.8% discount to the last closing price of 36.5 cents on 29 September.

Settlement of the shares is expected to occur on 8 October with allotment and commencement of trading on 11 October.

In addition, Xtek will also make a 1 for 3.7 pro-rata non-renounceable entitlement offer to all eligible security holders. The partially underwritten placement is seeking to raise a further $5 million on the same terms.

Approximately 19.2 million new shares will be added to the company’s registry.

The record date is scheduled to fall on Thursday, 7 October.

In total, $7.7 million will be raised to fund a number of initiatives for Xtek. These include:

• Development of an Australian-made small VTOL Unmanned Aerial Vehicles (UAV) for upcoming sales opportunities with the Australian Defence Force;
• Development of the next XTatlas actionable intelligence software applications;
• Expansion of the range of hard armour plates and helmets made using its patented XTclave process; and
• Provision of working capital required to grow the company’s business and meet ongoing financial obligations.

Xtek share price review

It’s been a woeful year for Xtek shares. They’ve gradually moved more than 50% lower over the past 12 months. It’s worth noting the company’s shares are currently trading at multi-year lows today.

Xtek presides a market capitalisation of about $19.89 million and has just over 71 million shares on its books.

The post Xtek (ASX:XTE) share price sinks 23% on capital raising efforts appeared first on The Motley Fool Australia.

More reading

• Want to invest in space? Here are 4 ASX shares

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3uBw94Q

The Fortescue Metals Group Limited (ASX: FMG) share price went on a disappointing run last month. This comes as the price of iron ore continued to sink amid pressure from Chinese policymakers to reduce dependence on Australia.

While the S&P/ASX 200 Index (ASX: XJO) is up 1.05% to 7,260 points today, Fortescue shares are down 1.24% to $14.39 apiece.

What’s dragging Fortescue shares lower?

Iron ore is currently fetching US$115.76 a tonne, plunging 19% since the beginning of September.

The Fortescue share price has trodden along the same lines, falling 30% over the same time.

Chinese lawmakers introduced new rules for its steel producers in an effort to curb reliance on Australian iron ore. Steel mills were instructed to limit 2021 output to no more than 2020 levels, or face penalties.

China wants its steel industry to halt iron ore production at roughly 1 billion tonne for 2021. Consequently, Chinese crude steel production has dropped 8% in July and 13% in August. September figures are still being compiled.

Nonetheless, the result has led the price of iron ore to shrink. And fears are mounting that it could reach as low as US$70 by the end of the year. This would essentially cut more than half of Fortescue’s profits when it was enjoying above US$200 for iron ore.

In addition, broader market weakness has been a hindrance on Fortescue shares. The ASX 200 benchmark index dropped about 3.2% in a month, and 4.6% off its record high of 7,632.8 points.

Fortescue share price snapshot

Up until the end of July, Fortescue shareholders were enjoying strong gains, hitting an all-time high of $26.58 apiece. That all came crashing down in the last two months, with its shares touching a low of $14.15 in late September.

Comparing to this time last year, Fortescue shares are down 10%, with year-to-date losses reaching 40%.

On valuation metrics, Fortescue commands a market capitalisation of roughly $44.86 billion and has approximately 3.1 billion shares on issue.

The post Why did the Fortescue (ASX:FMG) share price have such a lousy month in September? appeared first on The Motley Fool Australia.

More reading

• These were the 5 worst performing ASX shares in September
• Top brokers name 3 ASX shares to sell next week
• Why the Fortescue (ASX:FMG) share price was sold off in September
• These were the 5 worst performing ASX 200 shares in September
• Top brokers name 3 ASX shares to sell today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3iuurgG

The Intega Group Ltd (ASX: ITG) share price is soaring to new heights after the company entered a scheme implementation deed for a proposed takeover.

Intega has received a takeover bid that would see 100% of its shares bought for 90 cents apiece. The offer is a 58% premium on the Intega share price’s previous close and a 95% premium on its last undisturbed close.

That values the company at around $421 million. For context, Intega’s previous close saw it with a market capitalisation of around $238 million.

Unsurprisingly, the bid has sent Intega’s stock to a new record high.

At the time of writing, the Intega share price is 88 cents, 54.39% higher than its previous close and the highest the company’s stock has ever been.

Let’s take a closer look at the proposition posed to the engineering services provider.

Intega enters takeover agreements

The Intega share price is rocketing higher today as the company moves forward with a lavish acquisition offer.

The company posing the 90 cents bid is Kiwa NV, a Dutch company that provides testing, inspection, and certification services to businesses.

The companies have now entered a scheme implementation deed – the first step towards seeing the takeover realised.

Intega says the scheme implementation deed is the result of a strategic review the company undertook into its business.

Intega recommends its shareholders vote in favour of the scheme, as long as it doesn’t get a better offer.

Further, the company’s largest shareholder, Crescent Capital Partners Shareholders, has confirmed it will vote in favour of the takeover. Crescent Capital Partners Shareholders owns 52.1% of Intega’s shares

Making the takeover bid more exciting is the prospect of a special dividend.

If the takeover is delayed beyond December 2021 because Kiwa doesn’t receive Foreign Investment Review Board approval in time, it may have to pay Intega shareholders a special dividend.

That could see $2.3 million paid to Intega shareholders for each month the takeover is delayed between January 2022 and June 2022.

Commentary from management

Intega’s chair Neville Buch commented on the news:

The scheme provides an opportunity for Intega shareholders to realise their investment in Intega for cash at an attractive premium to where Intega has traded since its demerger from Cardo in 2019. After undertaking a comprehensive strategic review, the Intega board has concluded that the scheme is compelling for our shareholders.

 Intega share price snapshot

Today’s gains included, the Intega share price is 218% higher than it was at the start of 2021.

The company’s stock is also trading for 236% more than it was this time last year.

The post Intega (ASX: ITG) share price leaps 54% on takeover news appeared first on The Motley Fool Australia.

More reading

• Why did the Fortescue (ASX:FMG) share price have such a lousy month in September?
• 2 leading ASX e-commerce shares that could be buys in October 2021
• Up 7%, the Flight Centre (ASX:FLT) share price is surging. Here’s why
• A budget blowout and a volatile ASX 200. Scott Phillips on Weekend Sunrise
• How did ASX healthcare shares perform in the FY22 first quarter?

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned.

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3aiiYN7

The e-commerce ASX share sector could be a good place to look for opportunities.

Businesses in the online retail world can develop good profit margins thanks to the lack of a physical retail store network and the benefits of network effects.

Once a website has been developed, the increasing sales volumes are likely to lead to fixed costs becoming a smaller percentage of revenue.

Here are two to think about:

Temple & Webster Group Ltd (ASX: TPW)

Temple & Webster is one of the leading furniture and homewares businesses. It sells more than 200,000 products from hundreds of suppliers.

It operates through a drop-shipping model. This means the products are sent directly to customers by suppliers, which helps with fast delivery times and also means that Temple & Webster doesn’t need to hold as much inventory. It does actually have a private label range though.

The e-commerce ASX share says that it has a large addressable market with accelerating online adoption. Excluding business to business, in Australia the estimated market is worth around $16 billion, with less than 10% of that sold online (between $1.1 billion and $1.4 billion).

Temple & Webster also points out that it’s profitable with strong revenue growth, it’s capital light and debt free.

That revenue has grown really quickly, with an acceleration during COVID-19. FY21 revenue surged 85% higher to $326.3 million. Revenue per active customer increased 12% year on year because of customers buying more often and spending more when they do. In the first couple of months of FY22, revenue had grown another 49%.

Management point to the benefit of the tailwind with the ongoing adoption of online shopping because of structural and demographic shifts.

Adore Beauty Group Ltd (ASX: ABY)

Adore Beauty is another e-commerce ASX share that is benefiting from the high demand for products and services online.

It’s a retail platform that sells almost 11,000 products from 260 brands.

With the release of its FY21 result, it said that:

Adore Beauty is executing a clear and robust growth strategy to cement its online market leadership position, and it is well positioned to capture market share in a large and growing market benefiting from structural tailwinds.

Just like Temple & Webster, the business is also its average customer spend more. Annual revenue per active customer rose by 7% to $219, driven by “strong” customer retention and increasing average order value.

The business is experiencing higher levels of profitability. Whilst FY21 revenue grew 48% to $179.3 million, beating guidance, the gross profit margin increased by 1.2 percentage points to 33.1%. Despite the heavy levels of investing, earnings before interest, tax, depreciation and amortisation (EBITDA) jumped 53% to $7.6 million.

The e-commerce ASX share expects to maintain a 2% to 4% EBITDA margin in the short-term to medium-term while re-investing to drive above market growth. In the long-term, scale benefits are expected to increase operating leverage and deliver further EBITDA margin expansion.

In the first few weeks of FY22, Adore Beauty saw a revenue increase of 26% year on year.

It’s currently rated as a buy by the broker Morgan Stanley. The price target is $6. The broker is attracted to the potential of the business over the long-term.

The post 2 leading ASX e-commerce shares that could be buys in October 2021 appeared first on The Motley Fool Australia.

More reading

• These ASX shares could be top options for growth investors
• Why CSL, Domino’s, Temple & Webster, & Xero shares are tumbling
• 2 top ASX growth shares that might be worth buying
• 2 growing small cap ASX shares for your watchlist
• 2 excellent ASX growth shares analysts rate as buys

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Temple & Webster Group Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Adore Beauty Group Limited. The Motley Fool Australia has recommended Temple & Webster Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3D8dTTF

The Flight Centre Travel Group Ltd (ASX: FLT) share price is beginning its ascent to pre-COVID levels as travel optimism gathers momentum.

At the time of writing, Flight Centre shares are up 7.55% to a 20-month high of $23.50.

What’s driving the Flight Centre share price?

Travel shares are booming, globally

The US Global Jets Exchange Traded Fund (ETF) rallied 5.33% on Friday night, signalling a strong re-rate across travel-related shares.

The Jets ETF is comprised of companies in the air travel industry including airline operators, airports and terminal services.

The ETF holds mainly US airlines but also has exposure to the likes of Qantas Group Ltd (ASX: QAN) and Sydney Airport (ASX: SYD).

With a benchmark travel index like Jets rallying overnight, it could only mean good news for the Flight Centre share price.

Australia set to reopen borders

Last Friday, Prime Minister Scott Morrison announced international borders will reopen in November for states that reach 80 per cent vaccination rates.

“The government’s intention is that once changes are made in November, the current overseas travel restrictions related to COVID-19 will be removed and Australians will be able to travel subject to any other travel advice and limits, as long as they are fully vaccinated and those countries’ border settings allow,” Mr Morrison said in a statement.

He said the government is considering quarantine-free travel between some countries, such as New Zealand, when “it is safe to do so”.

According to the Australian Financial Review, “Ex-Australia, Britain, Europe (especially Greece), the United States, Singapore and Fiji, along with New Zealand, feature strongly in bookings”.

When the news first broke last Friday, the Flight Centre share price managed to eke out a 1.82% gain to $21.85 despite the S&P/ASX 200 Index (ASX: XJO) tumbling 2%.

Flight Centre shares begin the climb to pre-COVID levels

The Flight Centre share price is breaking to the upside following a steady stream of positive news for the travel industry.

It’s up 9.4% in October alone and rallied 34% in the past month.

That said, Flight Centre has a mountain to climb if it is to reach its pre-COVID levels of around $40 a share.

The post Up 7%, the Flight Centre (ASX:FLT) share price is surging. Here’s why. appeared first on The Motley Fool Australia.

More reading

• A budget blowout and a volatile ASX 200. Scott Phillips on Weekend Sunrise
• If you invested $1,000 in Flight Centre (ASX:FLT) shares a decade ago, here’s what it would be worth now
• These were the best performing ASX 200 shares last week
• The Flight Centre (ASX:FLT) share price is in the green today. Here’s why
• Qantas (ASX:QAN) share price rises as border opening set to be brought forward

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3mofr5g

Motley Fool Australia Chief Investment Officer Scott Phillips joined Weekend Sunrise on Sunday to discuss the unexpected $27 billion budget boost (and how quickly that evaporated), plus a volatile S&P/ASX 200 Index (ASX: XJO) and the outlook for the economy.

The post A budget blowout and a volatile ASX 200. Scott Phillips on Weekend Sunrise appeared first on The Motley Fool Australia.

More reading

• Is the ASX open and trading today?
• If you invested $1,000 in Flight Centre (ASX:FLT) shares a decade ago, here’s what it would be worth now
• A 15% correction? One expert’s advice for a sinking ASX 200
• 5 things to watch on the ASX 200 on Monday
• These were the worst performing ASX 200 shares last week

Motley Fool contributor Scott Phillips has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3BjU2QQ

As we make our way through the first half of FY22, equity markets have begun to shake up somewhat in the last few weeks.

The benchmark S&P/ASX 200 Index (ASX: XJO) has slumped almost 4.5% into the red over the last month, back to its May 2021 levels.

Leading the way is the S&P/ASX 200 Health Care Index (XHJ), which has slipped around 6% lower in the last month.

Let’s zoom out and look at how ASX healthcare shares have performed in Q1 FY22.

How did ASX healthcare shares go in Q1 FY22?

As a whole, ASX healthcare shares were in the green for the first quarter, in a robust performance on the local exchanges.

The ASX 200 Health Care index has climbed 1.3% this past quarter, and now leads the benchmark index over this time.

Broad weakness across the ASX has stemmed a 3-month decline for the major indices, with the S&P/ASX 200 handing back just over 1% in Q1.

So as it stands, taking a broad view, ASX healthcare shares outperformed the market in the first quarter of FY22.

Impressive gains are observed on the individual share level for Q1 in this sub-group.

For instance immunotherapy company Imugene Limited‘s (ASX: IMU) share price has climbed from 35 cents to 47.5 cents in the last quarter, a 36% jump.

Not to mention, the Imugene share price came off lows of 28 cents on 9 August to reach its all-time high in Q1 FY22.

Medicinal cannabis company Incannex Healthcare Ltd (ASX: IHL) was also a winner, with shareholders clipping the ticket on a 35% bump in its share price last quarter.

Ramsay Health Care Limited (ASX: RHC) shares were also climbers in Q1, delivering an outsized return of 11% after a healthy $6.80 per share gain from July to 30 September.

However, it wasn’t all rainbows for the sector, with some names coming in well behind the benchmarks.

After some excitement earlier in the year, the Little Green Pharma Ltd (ASX: LGP) share price made a 26% march down south from highs of 93 cents.

In and around the small to large cap names, there are instances of both underperformance and outsized returns.

Foolish takeaway

In the last month, the ASX healthcare indices have led the market’s losses. Within this group, some shares are outperforming while others are lagging behind their key benchmarks.

Nonetheless, as a whole, ASX healthcare shares appear to have outperformed the broad index in the last quarter.

The post How did ASX healthcare shares perform in the FY22 first quarter? appeared first on The Motley Fool Australia.

More reading

• Top brokers name 3 ASX shares to sell next week
• Ramsay (ASX:RHC) share price on watch on Friday after update
• The Incannex (ASX:IHL) share price has lost 20% in 4 weeks. What’s happening?
• 5 things to watch on the ASX 200 on Thursday
• Little Green Pharma (ASX:LGP) share price lifts as bosses reflect on a big year

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3D9FrIA